Sg Americas Securities, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 7,519 shares of RYTM stock, worth $421,966. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,519

Previous 33,727 77.71%

Holding current value

$421,966

Previous $1.39 Million 71.55%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$40.81 - $55.0 $1.07 Million - $1.44 Million	-26,208 Reduced 77.71%	7,519 $394,000
Q2 2024 Jul 12, 2024	BUY	$35.41 - $44.37 $928,237 - $1.16 Million	26,214 Added 348.92%	33,727 $1.39 Million
Q1 2024 May 06, 2024	BUY	$39.12 - $52.44 $508 - $681	13 Added 0.17%	7,513 $326,000
Q4 2023 Jan 12, 2024	SELL	$21.39 - $49.64 $799,429 - $1.86 Million	-37,374 Reduced 83.29%	7,500 $345,000
Q3 2023 Oct 13, 2023	BUY	$15.81 - $27.8 $709,457 - $1.25 Million	44,874 New	44,874 $1.03 Million
Q2 2022 Jul 29, 2022	SELL	$3.12 - $12.25 $15,968 - $62,695	-5,118 Reduced 6.01%	80,064 $332,000
Q1 2022 Apr 29, 2022	SELL	$6.13 - $12.24 $39,704 - $79,278	-6,477 Reduced 7.07%	85,182 $981,000
Q4 2021 Feb 07, 2022	SELL	$8.62 - $13.9 $152,091 - $245,251	-17,644 Reduced 16.14%	91,659 $915,000
Q3 2021 Nov 01, 2021	BUY	$11.68 - $20.72 $320,440 - $568,453	27,435 Added 33.51%	109,303 $1.43 Million
Q2 2021 Aug 12, 2021	SELL	$18.52 - $22.55 $91,044 - $110,855	-4,916 Reduced 5.66%	81,868 $1.6 Million
Q1 2021 May 13, 2021	SELL	$20.25 - $39.49 $484,056 - $943,968	-23,904 Reduced 21.6%	86,784 $1.85 Million
Q4 2020 Feb 04, 2021	BUY	$21.17 - $32.61 $431,656 - $664,917	20,390 Added 22.58%	110,688 $3.29 Million
Q3 2020 Nov 09, 2020	BUY	$18.13 - $30.61 $1.64 Million - $2.76 Million	90,298 New	90,298 $1.96 Million
Q2 2020 Jul 20, 2020	SELL	$14.41 - $25.35 $164,014 - $288,533	-11,382 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$13.16 - $22.9 $50,494 - $87,867	-3,837 Reduced 25.21%	11,382 $173,000
Q4 2019 Jan 28, 2020	SELL	$19.53 - $25.5 $1.1 Million - $1.44 Million	-56,422 Reduced 78.76%	15,219 $349,000
Q3 2019 Nov 04, 2019	BUY	$18.62 - $24.51 $1.33 Million - $1.76 Million	71,641 New	71,641 $1.55 Million

Others Institutions Holding RYTM

# of Institutions

191

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Rhythm Pharmaceuticals, Inc. Transaction History